|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,565.00 ARS | -1.88% |
|
-1.57% | -20.76% |
| Market Cap | 13TCr 8.82Cr 7.6Cr 7Cr 6.57Cr 12Cr 833.5Cr 12Cr 83Cr 32Cr 408.17Cr 33Cr 32Cr 1.41TCr | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 36TCr 25Cr 21Cr 20Cr 19Cr 35Cr 2.36TCr 35Cr 233.8Cr 91Cr 1.15TCr 94Cr 92Cr 4TCr | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | -1.88% | ||
| 1 week | -1.57% | ||
| Current month | -4.57% | ||
| 1 month | -1.88% | ||
| 3 months | -9.01% | ||
| 6 months | -24.76% | ||
| Current year | -20.76% |
| 1 week | 1,530 | 1,640 | |
| 1 month | 1,520 | 1,725 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 208.5 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.88% | -1.57% | +7.93% | +205.07% | 8.82Cr | ||
| -0.61% | -1.94% | +39.00% | +150.72% | 1,00100Cr | ||
| -0.20% | -0.77% | +51.51% | +43.20% | 57TCr | ||
| +0.40% | -1.31% | +16.56% | +60.47% | 39TCr | ||
| +0.48% | +2.29% | +24.04% | +16.53% | 33TCr | ||
| +0.66% | +1.16% | +26.00% | +32.55% | 28TCr | ||
| +0.65% | -0.63% | +25.48% | +14.88% | 28TCr | ||
| +3.63% | +2.97% | -40.27% | -46.16% | 19TCr | ||
| -0.77% | +0.95% | +17.69% | +51.46% | 19TCr | ||
| +2.36% | +1.38% | +14.80% | +61.34% | 16TCr | ||
| Average | +0.56% | +0.16% | +18.27% | +59.01% | 33.77TCr | |
| Weighted average by Cap. | +0.47% | -0.41% | +28.03% | +67.53% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.18TCr 6.4Cr 5.52Cr 5.08Cr 4.77Cr 8.96Cr 605.42Cr 9.05Cr 60Cr 23Cr 296.48Cr 24Cr 24Cr 1.03TCr | 13TCr 8.84Cr 7.62Cr 7.02Cr 6.59Cr 12Cr 835.81Cr 12Cr 83Cr 32Cr 409.3Cr 33Cr 32Cr 1.42TCr |
| Net income | 2.38TCr 1.66Cr 1.43Cr 1.32Cr 1.24Cr 2.33Cr 157.27Cr 2.35Cr 16Cr 6.08Cr 77Cr 6.24Cr 6.11Cr 266.9Cr | 308.78Cr 21.54L 18.56L 17.09L 16.05L 30.13L 20Cr 30.45L 2.02Cr 78.69L 9.97Cr 80.84L 79.12L 35Cr |
| Net Debt | 13TCr 9.32Cr 8.03Cr 7.4Cr 6.95Cr 13Cr 881.46Cr 13Cr 87Cr 34Cr 431.65Cr 35Cr 34Cr 1.5TCr | 23TCr 16Cr 14Cr 13Cr 12Cr 23Cr 1.52TCr 23Cr 151.13Cr 59Cr 746.2Cr 60Cr 59Cr 2.59TCr |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 1,565.00 $ | -1.88% | 4,012 |
| 12/26/12 | 1,595.00 $ | -1.85% | 2,362 |
| 11/26/11 | 1,625.00 $ | +1.88% | 2,208 |
| 10/26/10 | 1,595.00 $ | +0.31% | 5,402 |
| 09/26/09 | 1,590.00 $ | -0.31% | 35,894 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















